Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Thrombocytopenia 14Leukemia, Myeloid, Acute 5Leukemia 3Jacobs syndrome 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Sarcoma 1Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Primary Myelofibrosis 1Pathologic Complete Response 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Chemotherapy-induced Thrombocytopenia 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

fludarabine phosphate 16Cyclophosphamide 16Antilymphocyte Serum 13Mycophenolic Acid 11Busulfan 11Radiotherapy 9Melphalan 9Cyclosporine 9Cord Blood Stem Cell Transplantation 9Peripheral Blood Stem Cell Transplantation 8Methylprednisolone 8Whole-Body Irradiation 6Tacrolimus 6Filgrastim 6Methotrexate 4fludarabine 3thymoglobulin 2Etoposide 2Cytarabine 2sargramostim 1niraparib 1merphos 1fanasil, pyrimethamine drug combination 1eltrombopag 1darinaparsin 1Transplantation 1Thiotepa 1Therapeutics 1Sirolimus 1Pharmacokinetics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × eltrombopag × Classical hematology × Clear all
NCT01484314 2017-03-15

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Dana-Farber Cancer Institute

Phase 2 Terminated
1 enrolled 1 chart
Classical hematologyPlasma cell

Multiple Myeloma, Recurrence, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡